Physician
Deobhakta, Avnish
Deobhakta, Avnish was paid $141K by Medicaid between Jan 2018 and Nov 2024, across 14 billing codes. Its largest line is J0178, Injection, aflibercept, 1 mg — 51% of everything it billed.
33Billing provider infoDEOBHAKTA, AVNISH
BOSTON, MA 02215
BOSTON, MA 02215
33aNPI1356518674assigned 05/15/2008
33bProvider typeRetina Specialist (Ophthalmology) Physician
28Total paid$141K
24GClaims7,514
24DCodes billed14
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Retina Specialist (Ophthalmology) Physician providers in Massachusetts
Rank by total paid#2 of 10
Median peer was paid$5K
This provider vs. median26×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,626 | $12K | |
| 2019 | 1,354 | $40K | |
| 2020 | 787 | $25K | |
| 2021 | 578 | $10K | |
| 2022 | 953 | $23K | |
| 2023 | 1,177 | $16K | |
| 2024incomplete | 1,039 | $16K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 51% | 179 | 165 | $72K |
| 67028 | Intravitreal injection of a pharmacologic agent | 14% | 1,231 | 1,152 | $20K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 12% | 993 | 985 | $17K |
| 92134 | 8.8% | 2,829 | 2,712 | $12K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 7.2% | 1,284 | 1,204 | $10K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.2% | 228 | 226 | $3K |
| J9035 | Injection, bevacizumab, 10 mg | 1.7% | 103 | 95 | $2K |
| 92201 | <1% | 268 | 266 | $1K | |
| 92226 | <1% | 244 | 205 | $1K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 25 | 25 | $915.57 |
| 92225 | <1% | 48 | 41 | $289.49 | |
| 92250 | <1% | 16 | 16 | $52.23 |
2 more codes
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 0% | 54 | $0.00 |
| 2022F | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.